These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 19028594

  • 1. Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response.
    Trocoli Torrecilhas AC, Tonelli RR, Pavanelli WR, da Silva JS, Schumacher RI, de Souza W, E Silva NC, de Almeida Abrahamsohn I, Colli W, Manso Alves MJ.
    Microbes Infect; 2009 Jan; 11(1):29-39. PubMed ID: 19028594
    [Abstract] [Full Text] [Related]

  • 2. In vivo infection by Trypanosoma cruzi: the conserved FLY domain of the gp85/trans-sialidase family potentiates host infection.
    Tonelli RR, Torrecilhas AC, Jacysyn JF, Juliano MA, Colli W, Alves MJ.
    Parasitology; 2011 Apr; 138(4):481-92. PubMed ID: 21040619
    [Abstract] [Full Text] [Related]

  • 3. Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities.
    Roggero E, Perez A, Tamae-Kakazu M, Piazzon I, Nepomnaschy I, Wietzerbin J, Serra E, Revelli S, Bottasso O.
    Clin Exp Immunol; 2002 Jun; 128(3):421-8. PubMed ID: 12067296
    [Abstract] [Full Text] [Related]

  • 4. Dogs infected with the blood trypomastigote form of Trypanosoma cruzi display an increase expression of cytokines and chemokines plus an intense cardiac parasitism during acute infection.
    de Souza SM, Vieira PM, Roatt BM, Reis LE, da Silva Fonseca K, Nogueira NC, Reis AB, Tafuri WL, Carneiro CM.
    Mol Immunol; 2014 Mar; 58(1):92-7. PubMed ID: 24317279
    [Abstract] [Full Text] [Related]

  • 5. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.
    Chuenkova M, Pereira ME.
    J Exp Med; 1995 May 01; 181(5):1693-703. PubMed ID: 7722448
    [Abstract] [Full Text] [Related]

  • 6. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection.
    Michailowsky V, Silva NM, Rocha CD, Vieira LQ, Lannes-Vieira J, Gazzinelli RT.
    Am J Pathol; 2001 Nov 01; 159(5):1723-33. PubMed ID: 11696433
    [Abstract] [Full Text] [Related]

  • 7. Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.
    Silverio JC, de-Oliveira-Pinto LM, da Silva AA, de Oliveira GM, Lannes-Vieira J.
    Int J Exp Pathol; 2010 Feb 01; 91(1):72-86. PubMed ID: 19878357
    [Abstract] [Full Text] [Related]

  • 8. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites.
    Marinho CR, Nuñez-Apaza LN, Martins-Santos R, Bastos KR, Bombeiro AL, Bucci DZ, Sardinha LR, Lima MR, Alvarez JM.
    Scand J Immunol; 2007 Feb 01; 66(2-3):297-308. PubMed ID: 17635807
    [Abstract] [Full Text] [Related]

  • 9. Trypanosoma cruzi: peripheral blood monocytes and heart macrophages in the resistance to acute experimental infection in rats.
    Melo RC, Machado CR.
    Exp Parasitol; 2001 Jan 01; 97(1):15-23. PubMed ID: 11207110
    [Abstract] [Full Text] [Related]

  • 10. Trypanosoma cruzi strains cause different myocarditis patterns in infected mice.
    Rodriguez HO, Guerrero NA, Fortes A, Santi-Rocca J, Gironès N, Fresno M.
    Acta Trop; 2014 Nov 01; 139():57-66. PubMed ID: 25017312
    [Abstract] [Full Text] [Related]

  • 11. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
    Fontanella GH, De Vusser K, Laroy W, Daurelio L, Nocito AL, Revelli S, Contreras R.
    Vaccine; 2008 May 02; 26(19):2322-34. PubMed ID: 18403070
    [Abstract] [Full Text] [Related]

  • 12. Impact of Trypanosoma cruzi infection on nitric oxide synthase and arginase expression and activity in young and elderly mice.
    Felizardo AA, Caldas IS, Mendonça AAS, Gonçalves RV, Tana FL, Almeida LA, Novaes RD.
    Free Radic Biol Med; 2018 Dec 02; 129():227-236. PubMed ID: 30248443
    [Abstract] [Full Text] [Related]

  • 13. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
    Garcia S, Ramos CO, Senra JF, Vilas-Boas F, Rodrigues MM, Campos-de-Carvalho AC, Ribeiro-Dos-Santos R, Soares MB.
    Antimicrob Agents Chemother; 2005 Apr 02; 49(4):1521-8. PubMed ID: 15793134
    [Abstract] [Full Text] [Related]

  • 14. American trypanosomosis: in situ and generalized features of parasitism and inflammation kinetics in a murine model.
    Monteón VM, Furuzawa-Carballeda J, Alejandre-Aguilar R, Aranda-Fraustro A, Rosales-Encina JL, Reyes PA.
    Exp Parasitol; 1996 Aug 02; 83(3):267-74. PubMed ID: 8823243
    [Abstract] [Full Text] [Related]

  • 15. 5-lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection.
    Pavanelli WR, Gutierrez FR, Mariano FS, Prado CM, Ferreira BR, Teixeira MM, Canetti C, Rossi MA, Cunha FQ, Silva JS.
    Microbes Infect; 2010 Aug 02; 12(8-9):587-97. PubMed ID: 20381637
    [Abstract] [Full Text] [Related]

  • 16. Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditis.
    Silva MC, Davoli-Ferreira M, Medina TS, Sesti-Costa R, Silva GK, Lopes CD, Cardozo LE, Gava FN, Lyroni K, Dias FC, Frade AF, Baron M, Nakaya HI, Figueiredo F, Alves-Filho JC, Cunha FQ, Tsatsanis C, Chevillard C, Cunha-Neto E, Hirsch E, Silva JS, Cunha TM.
    Nat Commun; 2018 Apr 17; 9(1):1513. PubMed ID: 29666415
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA, Vicco MH, Cabrera G, Villar SR, González FB, Roggero EA, Ameloot P, Callewaert N, Pérez AR, Marcipar IS.
    Vaccine; 2015 Mar 03; 33(10):1274-83. PubMed ID: 25625671
    [Abstract] [Full Text] [Related]

  • 18. Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.
    Vasconcelos JR, Hiyane MI, Marinho CR, Claser C, Machado AM, Gazzinelli RT, Bruña-Romero O, Alvarez JM, Boscardin SB, Rodrigues MM.
    Hum Gene Ther; 2004 Sep 03; 15(9):878-86. PubMed ID: 15353042
    [Abstract] [Full Text] [Related]

  • 19. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC, Curotto de Lafaille MA, Collet de Araujo Lima GM, de Almeida Abrahamsohn I.
    Cell Immunol; 1996 May 25; 170(1):41-53. PubMed ID: 8660798
    [Abstract] [Full Text] [Related]

  • 20. Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage.
    Medeiros GA, Silvério JC, Marino AP, Roffê E, Vieira V, Kroll-Palhares K, Carvalho CE, Silva AA, Teixeira MM, Lannes-Vieira J.
    Microbes Infect; 2009 Feb 25; 11(2):264-73. PubMed ID: 19100857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.